Brivo SPAC Presentation Deck

Risk related to the SPAC and the business combination • We may be subject to additional tax liabilities, which could harm our results of operations. The market prices of shares of the Post-Combination Company's common stock may be affected by factors different from those currently affecting the prices of shares of the SPAC's common stock. ● ● If the Business Combination's benefits do not meet the expectations of financial analysts, the market price of the Post-Combination Company's common stock may decline. There can be no assurance that the Post-Combination Company's common stock will be approved for continued listing on the Nasdaq or that the Post-Combination Company will be able to comply with the continued listing standards of Nasdaq. ● • The consummation of the Business Combination is subject to a number of conditions and if those conditions are not satisfied or waived, the Business Combination Agreement may be terminated in accordance with its terms and the Business Combination may not be completed. • The parties to the Business Combination Agreement may amend the terms of the Business Combination Agreement or waive one or more of the conditions to the Business Combination, and the exercise of discretion by the SPAC's directors and officers in agreeing to changes to the terms of or waivers of closing conditions in the Business Combination Agreement may result in a conflict of interest when determining whether such changes to the terms of the Business Combination Agreement or waivers of conditions are appropriate and in the best interests of our stockholders. Termination of the Business Combination Agreement could negatively impact Brivo and the SPAC. • Brivo will be subject to business uncertainties and contractual restrictions while the Business Combination is pending. • The Sponsor, Brivo's directors and officers, and the SPAC's directors and officers may each have interests in the Business Combination different from the interests of Brivo's or the SPAC's stockholders. ● • The Business Combination will result in changes to our board of directors that may affect our strategy. • The Business Combination Agreement will contain provisions that may discourage other companies from trying to acquire Brivo for greater merger consideration. • The Business Combination Agreement will contain provisions that may discourage the SPAC from seeking an alternative business combination. • The unaudited pro forma condensed combined financial information included in this presentation is preliminary and the actual financial condition and results of operations after the Business Combination may differ materially. Brivo and the SPAC will incur significant transaction costs in connection with the Business Combination. • Brivo's and the SPAC's ability to consummate the Business Combination, and the operations of the Post-Combination Company following the Business Combination, may be materially adversely affected by the recent COVID-19 pandemic. ● Obrivo. 46

View entire presentation